Licensed Controlled Substance Testing for Research & Pharma
CAL Laboratories is a Health Canada–licensed and ISO 17025:2017 accredited facility offering controlled substance testing for pharmaceutical, clinical research, and regulatory purposes. Our secure, GMP-compliant infrastructure supports the safe handling and analysis of narcotics, psychedelics, stimulants, and Precursor Class A substances under the Controlled Drugs and Substances Act (CDSA).
Comprehensive Testing Services for Controlled Substances
Our services include:
- Active pharmaceutical ingredient (API) assay
- Potency testing and quantification
- Impurity profiling and residual solvent analysis
- Stability testing under ICH conditions
All testing is conducted using validated pharmacopeial methods (USP, EP) or custom-developed protocols, with full chain-of-custody documentation.
Substance Categories We Are Licensed to Test:
- Opioids: Morphine, Codeine, Fentanyl, Oxycodone
- Stimulants: Amphetamine, Methylphenidate
- Benzodiazepines: Diazepam, Alprazolam, Lorazepam
- Psychedelics: Psilocybin and Psilocin (under Section 56 exemptions)
Precursor Class A Substance Testing
We are authorized to test controlled chemical precursors used in pharmaceutical and consumer health products:
- Ephedrine & Ephedrine HCl
- Pseudoephedrine
- Phenyl-2-propanone (P2P)
- Norephedrine
These substances are regulated to prevent diversion into illicit drug synthesis and require precise analytical and physical security controls.
Testing Support for Research & Development CAL supports:
- Clinical trial testing (Phase I-III)
- Formulation verification
- Stability programs for regulatory submission
- NDS submissions and dossier support for controlled ingredients
Secure, Licensed Testing Infrastructure Our facility maintains:
- Health Canada Controlled Drugs & Precursor Licenses
- ISO 17025:2017 Accreditation
- Controlled access and secure handling systems
- Regulatory audit readiness and full documentation
Controlled Substance Testing FAQs: Licensing, Methods & Compliance
We are licensed by Health Canada to test controlled substances, precursors, and Schedule I psychedelics (psilocybin/psilocin).
Only licensed producers, pharmaceutical manufacturers, and authorized research institutions may submit samples.
Opioids, stimulants, benzodiazepines, psychedelics, and Precursor Class A compounds.
Yes. Our validated methods meet Health Canada, FDA, and ICH guidelines for GMP and pharmaceutical filings.
Yes. We are licensed to receive, handle, and test psilocybin and psilocin under legal exemptions for scientific research.